AbbVie Inc (ABBV)
Healthcare
Drug Manufacturers - General
250.90 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns AbbVie Inc (ABBV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 76.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
76.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
1,767Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 10.23 | 180,779,699 | +1.7 | 12/31/2025 |
| BlackRock Inc | 8.53 | 150,698,125 | -0.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.50 | 114,880,324 | +0.0 | 03/31/2026 |
| State Street Corp | 4.60 | 81,217,516 | +0.3 | 03/31/2026 |
| JPMorgan Chase & Co | 3.21 | 56,741,691 | +8.3 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.80 | 49,523,078 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.65 | 46,737,581 | +4.7 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 2.15 | 38,016,774 | -5.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.19 | 56,342,173 | +0.3 | 04/30/2026 |
| Vanguard 500 Index Investor | 2.59 | 45,827,853 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.